India to Chile Pharmaceutical Export (2026) — $230.4M, 261 Suppliers | TransData Nexus

India to Chile Pharmaceutical Export (2026) — $230.4M, 261 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Chile

#	Formulation	Value	Share
1	Pharma Drug&med: Tellmi Telmisart.40mg Each Uncoated Tablet Contains: Telmisart…	$8.7M	3.8%
2	Human Normal Immunoglobulin for Intravenous Administration B.p.5% Solution 100ml	$3.3M	1.5%
3	Tramadol Hydrochloride/ Paracetamol 37.5/325mg Tablets Pack of 3x10 (each Coate…	$2.4M	1.0%
4	Drolsan 200mg Tablets (15480 X 3 X 10's= 464400 Tbs)	$2.0M	0.9%
5	Heparin Injection BP 25000iu/5ml, 5ml Vialnos	$1.8M	0.8%
6	Human Normal Immunoglobulin for Intravenous Administration B.p.5% Solution 100m…	$1.6M	0.7%
7	Metformin Tablets B.p. 850mg Pack of 120x10"s	$1.4M	0.6%
8	Human Normal Immunoglobulin for Intravenous Administration B P 5 Solution 100ml…	$1.3M	0.5%
9	Human Normal Immunoglobulin for Intraven	$1.1M	0.5%
10	Ibuprofeno 600mg X 20 Comp (be) (pharmaceuticals)	$1.1M	0.5%
11	Compresso Pap 90 Cpc	$1.0M	0.4%
12	Urofenil Tablets	$1.0M	0.4%
13	Heparin Injection Bp, 25000iu/5ml, 5ml Vial	$930.0K	0.4%
14	Flusacort Salmeterol+fluticasone Propionate Inhaler	$926.9K	0.4%
15	Venlafaxina 75mg 50x10s Capsules Ap Chl	$904.1K	0.4%

India exports 20+ pharmaceutical formulations to Chile with a combined trade value of $230.4M. Key products include Immunoglobulin ($3.3M), Tramadol ($2.4M), Heparin ($1.8M), Metformin ($1.4M), Salmeterol ($927K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 10,417 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to Chile Trade Routes

1Immunoglobulin$3.3M 2Tramadol$2.4M 3Heparin$1.8M

4Metformin$1.4M

5Salmeterol

Top Indian Exporters to Chile

1Alkem Laboratories Limited

$22.0M

2Pinnacle Life Science Private Limited

$14.0M

3Msn Laboratories Private Limited

$13.3M

4Intas Pharmaceuticals Limited

$11.9M

Port Analysis — India to Chile Pharmaceutical Shipments

Indian Export Ports

NHAVA SHEVA SEA (INNSA1)14.9%

DELHI AIR3.4%

JNPT5.9%

HYDERABAD ICD3.8%

JNPT/ NHAVA SHEVA SEA9.9%

Chile Import Ports

San Antonio16.2%

SANTIAGO DE CHILE -33.1%

Valparaiso7.8%

SAN ANTONIO11.4%

VALPARAISO7.4%

Trade Statistics

Total Value$230.4M

Shipments10,417

Indian Exporters261

Chile Buyers512

Avg Shipment$22K

Products6,420

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B France

Last updated: March 28, 2026

India–Chile Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade between India and Chile has experienced significant growth over the past decade. In 2024, India's pharmaceutical exports to Chile reached approximately $200.57 million, marking a substantial increase from previous years. This upward trajectory reflects the strengthening economic ties and the growing demand for affordable, high-quality medicines in Chile. The expansion is also attributed to India's competitive manufacturing capabilities and adherence to international quality standards, which have bolstered its position in the global pharmaceutical market.

Key milestones in this bilateral trade include the signing of the Partial Scope Trade Agreement in 2007, which was deepened in 2017, providing tariff preferences ranging from 20% to 100% for pharmaceutical products. This agreement has facilitated smoother trade flows and enhanced market access for Indian pharmaceutical companies.

2India's Market Position

India holds a significant share in Chile's pharmaceutical import market, ranking third or fourth among Chile's pharmaceutical import sources as of 2023. This position underscores India's strategic importance in supplying essential medicines to Chile. The country's robust pharmaceutical industry, characterized by a vast array of generic medicines and adherence to international quality standards, makes it a preferred partner for Chilean importers seeking cost-effective and reliable pharmaceutical products.

Chile Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1Registration Process

Indian pharmaceutical companies seeking to register products in Chile must comply with the regulations set by the Public Health Institute (Instituto de Salud Pública or ISP), the regulatory authority responsible for controlling pharmaceutical products in Chile. The registration process involves submitting detailed information about the pharmaceutical products, including their composition, intended use, packaging, labeling, and manufacturer information. Additionally, the products must meet the World Health Organization's Good Manufacturing Practices (WHO-GMP) standards to ensure quality and safety. (britcham.cl)

The registration dossier should be prepared in the Common Technical Document (CTD) format, which is internationally recognized and facilitates the evaluation process. The timeline for registration can vary, but it typically involves a thorough review by the ISP, which may take several months. Therefore, Indian exporters should plan accordingly and ensure that all documentation is complete and accurate to expedite the approval process.

2GMP & Facility Requirements

Chile requires that pharmaceutical products imported into the country comply with Good Manufacturing Practices (GMP) standards. The ISP is responsible for implementing and enforcing GMP compliance, conducting inspections, and ensuring that pharmaceutical manufacturers adhere to the prescribed guidelines. Indian manufacturing sites must demonstrate adherence to these standards, which may involve providing evidence of GMP certification from recognized authorities.

The inspection process includes evaluating the manufacturing facilities, quality control measures, and documentation practices to ensure that the products meet the required quality and safety standards. Mutual recognition agreements between regulatory authorities can streamline this process, but Indian exporters should be prepared for potential inspections and ensure that their facilities are compliant with both Indian and international GMP standards.

3Import Documentation

Importing pharmaceutical products into Chile requires obtaining authorization from the ISP. The authorization process involves submitting detailed information about the pharmaceutical products, including their composition, intended use, packaging, labeling, and manufacturer information. Additionally, importers must provide certificates such as the Certificate of Pharmaceutical Product (CPP), Certificate of Analysis (CoA), and evidence of GMP compliance. (britcham.cl)

Customs procedures for pharmaceutical imports into Chile include submitting the necessary documentation to the ISP for approval, followed by clearance through Chilean customs. It is essential for importers to adhere to all regulations and requirements set forth by the Chilean health authorities to avoid any potential issues or delays in the importation process.

TransData Nexus Research · Chile regulatory databasesMar 2026

Product Categories & Therapeutic Trends — India to Chile

Dominant categories, emerging opportunities, and demand drivers

1Dominant Categories

The dominant therapeutic areas in India's pharmaceutical exports to Chile include drugs for the nervous system, anti-infectives for systemic use, and medications for the gastrointestinal tract and metabolism. In 2022, these categories accounted for the majority of pharmaceutical sales in Chile, with drugs for the nervous system at $486.4 million, anti-infectives for systemic use at $447.7 million, and medications for the gastrointestinal tract and metabolism at $571.3 million.

This trend aligns with Chile's healthcare needs, as these therapeutic areas address prevalent health concerns in the country. The demand for such medications presents a significant opportunity for Indian pharmaceutical exporters to cater to the Chilean market by providing cost-effective and high-quality products in these categories.

2Emerging Opportunities

The global pharmaceutical industry is witnessing patent expirations, leading to increased demand for generic medicines. Additionally, the rising prevalence of chronic diseases and the need for affordable healthcare solutions are driving the demand for biosimilars and other therapeutic areas. Indian pharmaceutical exporters can leverage these trends by focusing on developing and supplying generic versions of off-patent drugs and biosimilars to the Chilean market.

By aligning their product portfolios with these emerging opportunities, Indian exporters can strengthen their presence in Chile and contribute to meeting the country's evolving healthcare needs.

3Demand Drivers

Chile's disease burden, aging population, and increasing healthcare spending are significant drivers of import demand for pharmaceutical products. The country's healthcare system is under pressure to provide effective treatments for a growing number of chronic diseases and age-related health issues. This situation creates a substantial market for pharmaceutical imports, particularly for cost-effective and high-quality medicines.

The Chilean government's efforts to improve healthcare infrastructure and expand insurance coverage further contribute to the rising demand for pharmaceutical products. Indian exporters can capitalize on these trends by offering a diverse range of products that meet the needs of the Chilean population.

TransData Nexus Research · DGFT trade data analysisMar 2026

FAQ — India to Chile Pharmaceutical Trade

What is the total value of India's pharmaceutical export to Chile?

India exported pharmaceuticals worth $230.4M to Chile across 10,417 verified shipments.

Who are the top Indian pharmaceutical exporters to Chile?

1. ALKEM LABORATORIES LIMITED — $22.0M. 2. PINNACLE LIFE SCIENCE PRIVATE LIMITED — $14.0M. 3. MSN LABORATORIES PRIVATE LIMITED — $13.3M. Total: 261 suppliers.

Which companies in Chile import pharmaceuticals from India?

1. ASCEND LABORATORIES SPA — $18.6M. 2. OPKO CHILE S.A. — $11.4M. 3. LABORATORIOS SAVAL S.A. — $8.9M. 512 buyers total.

What pharmaceutical products does India export most to Chile?

1. Pharma Drug&med: Tellmi Telmisart.40mg Each Uncoated Tablet Contains: Telmisart… ($8.7M, 3.8%); 2. Human Normal Immunoglobulin for Intravenous Administration B.p.5% Solution 100ml ($3.3M, 1.5%); 3. Tramadol Hydrochloride/ Paracetamol 37.5/325mg Tablets Pack of 3x10 (each Coate… ($2.4M, 1.0%); 4. Drolsan 200mg Tablets (15480 X 3 X 10's= 464400 Tbs) ($2.0M, 0.9%); 5. Heparin Injection BP 25000iu/5ml, 5ml Vialnos ($1.8M, 0.8%)

Which ports handle pharmaceutical shipments from India to Chile?

Export: NHAVA SHEVA SEA (INNSA1), DELHI AIR, JNPT, HYDERABAD ICD, JNPT/ NHAVA SHEVA SEA. Import: San Antonio, SANTIAGO DE CHILE -, Valparaiso, SAN ANTONIO, VALPARAISO.

Why does Chile import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $230.4M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Chile?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Chile pharmaceutical trade?

$22.1K per consignment across 10,417 shipments.

How many Indian pharmaceutical companies export to Chile?

261 Indian companies. Largest: ALKEM LABORATORIES LIMITED with $22.0M.

How can I find verified Indian pharmaceutical suppliers for Chile?

TransData Nexus covers 261 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Chile identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 10,417 verified shipments from 261 Indian exporters to 512 Chile buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

261 Exporters

512 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Chile Pharmaceutical Export